摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3-seco-olean-12-en-2,3,28-trioic acid

中文名称
——
中文别名
——
英文名称
2,3-seco-olean-12-en-2,3,28-trioic acid
英文别名
(4aR)-1c.4ar.4bt.9.9-pentamethyl-1t-carboxymethyl-2c-(1-methyl-1-carboxy-ethyl)-(10acH.12atH)-Δ10b-tetradecahydro-6H-chrysene-carboxylic acid-(6ac);(4aR)-1c.4ar.4bt.9.9-Pentamethyl-1t-carboxymethyl-2c-(1-methyl-1-carboxy-aethyl)-(10acH.12atH)-Δ10b-tetradecahydro-6H-chrysen-carbonsaeure-(6ac);(1R,2R,4aR,4bS,6aS,10aS,12aR)-1-(carboxymethyl)-2-(2-carboxypropan-2-yl)-1,4a,4b,9,9-pentamethyl-3,4,5,6,7,8,10,10a,12,12a-decahydro-2H-chrysene-6a-carboxylic acid
2,3-seco-olean-12-en-2,3,28-trioic acid化学式
CAS
——
化学式
C30H46O6
mdl
——
分子量
502.692
InChiKey
UCCQVJRIXILWAE-DETCRYNISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.4
  • 重原子数:
    36
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    112
  • 氢给体数:
    3
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis of [2-13C]-oleanolic acid and [2-13C]-myricerone
    摘要:
    Synthetic way for C-13-labeled oleanolic acid I and myricerone 2 has been developed, starting from the parent 1 and 2. The procedure involves ring opening and closure of the A rings of these oleanane triterpenes. C-13 was introduced into the 2-position by C-13-MeLi as an isotope source. Chelation controlled addition of methyllithium to alpha-hydoxypentanone 11 is a common crucial step for labeling of 1 and 2, and judicious choice of protecting groups is essential for 2. (C) 1999 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4020(99)00975-8
  • 作为产物:
    描述:
    3-氧代-12-烯-28-齐墩果酸双氧水sodium methylate 作用下, 以 甲醇 为溶剂, 反应 25.0h, 生成 2,3-seco-olean-12-en-2,3,28-trioic acid
    参考文献:
    名称:
    Synthesis of [2-13C]-oleanolic acid and [2-13C]-myricerone
    摘要:
    Synthetic way for C-13-labeled oleanolic acid I and myricerone 2 has been developed, starting from the parent 1 and 2. The procedure involves ring opening and closure of the A rings of these oleanane triterpenes. C-13 was introduced into the 2-position by C-13-MeLi as an isotope source. Chelation controlled addition of methyllithium to alpha-hydoxypentanone 11 is a common crucial step for labeling of 1 and 2, and judicious choice of protecting groups is essential for 2. (C) 1999 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4020(99)00975-8
点击查看最新优质反应信息

文献信息

  • Synthesis and evaluation of A-seco type triterpenoids for anti-HIV-1protease activity
    作者:Ying Wei、Chao-Mei Ma、Masao Hattori
    DOI:10.1016/j.ejmech.2009.05.002
    日期:2009.10
    2,3-Seco-dioic acids derived from four different triterpene skeletons were prepared and evaluated for their anti-HIV-1 protease activity. Two A-seco derivatives showed potent inhibitory activity against HIV-1 protease (3c and 3e, IC50 5.7 and 3.9 mu M, respectively), while four other derivatives showed moderate to weak inhibition (3a, 3b, 3d and 3f, IC50 15.7-88.1 mu M). The combination of a 2,3-seco-2,3-dioic acid functional group in ring A and a free acid group at C-28 or C-30 significantly enhanced HIV-1 protease inhibitory activity (3a, 3c-3e, IC50 3.9-17.6 mu M). On the other hand, all A-seco derivatives were found to be very weak inhibitors of HCV, renin and trypsin proteases (IC50 > 80 mu M). These findings indicate that A-seco triterpenes with a carboxyl group at C-28 or C-30 are novel and highly selective HIV-1 protease inhibitors. (C) 2009 Elsevier Masson SAS. All rights reserved.
  • Zur Kenntnis der Triterpene. 39. Mitteilung. Aufspaltung des Ringes A der Oleanolsäure
    作者:L. Ruzicka、F. Ch. Van Der Sluys-Veer
    DOI:10.1002/hlca.193802101169
    日期:——
  • Surfacevs intramuscular laryngeal electromyography
    作者:Thomas M. Hemmerling、J. Schmidt、Tobias Wolf、Stephan R Wolf、Klaus E. Jacobi
    DOI:10.1007/bf03019665
    日期:2000.9
    Purpose: To compare surface and intramuscular laryngeal electromyography (EMG) with adductor pollicis muscle EMG after 0.1 mg.kg(-1) cisatracunium.Methods: This prospective study included ten patients undergoing surgery with risk of damage to the recurrent laryngeal nerve (RLN), The tracheas were intubated after fentanyl/propoiol without the aid of muscle relaxation. A surface laryngeal electrode was attached to the tube and placed amidst the vocal cords; two straight needles were inserted endoscopically into the lek lateral cricoarytenoid muscle. Single twitch stimulation of the left RLN (0.1 Hz) was performed transcutaneously; skin EMG of the left adductor pollicis muscle was performed at 0.1 Hz. After supramaximal stimulation for 10 min, 0.1 mg.kg(-1) cisatracurium was injected. Lag, onset time and peak effect were measured and compared.Results: Good correlation (r = 0.9, 0.8, p < 0.005) and good comparability of the two methods of laryngeal EMG (mean difference and limits of agreement: 0 +/- 28 sec for lag time, -2 +/- 84 sec for onset time) was shown, The mean surface laryngeal lag and onset times were 67 +/- 22 sec and 198 +/- 72 sec, compared with the adductor pollicis muscle (98 +/- 30 sec and 242 +/- 59 sec) at P < 0.01. Peak effects at larynx (92 +/- 9%) and adductor pollicis muscle (95 +/- 3%) were similarConclusion: Surface laryngeal EMG is comparable to intramuscular laryngeal EMG to determine degree and onset of the neuromuscular blockade, Increasing muscle relaxation does not cause the surface electrode to lose contact with the vocal cords and therefore underestimate onset time and peak effect.
查看更多

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B